- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05280119
Efficacy of the echOpen Device to Identify Effusion and to Detect Basilic Vein (CLIN-ECHO-I)
Assessment of the echOpen Ultra-portable Ultrasound Device in Daily Use by Clinicians. Part I: Identification of Effusion and Detection of Basilic Vein
In recent years, portable and ultra-portable ultrasound devices are increasingly used by the non radiologists, notably cardiologists or obstetrician gynecologist, at the patient's bedside to visualize and measure anatomical structures and fluid and provide the clinical examination with additional signs allowing quicker and more confident clinical decisions.
This innovative approach is slowed down by the accessibility of these miniaturized devices, the price of which remains high.
The echOpen device includes an ultra-portable ultrasound probe and a mobile application that allows the image to be displayed on a smartphone via a WIFI protocol.
The objective of the clinical investigation is to show that the echOpen device, using three frequencies 3.5 Mhz, 5.0 Mhz and 7.5 Mhz, allows identifying the semiological signs or anatomical structures of interest located at several depths of the body, with a performance similar to other devices routinely used in clinical departments.
Study Overview
Status
Detailed Description
The echOpen device includes an ultrasound probe and a mobile application. The mechanical probe emits at three ultrasound frequencies, 3.5 Mhz, 5.0 Mhz and 7.5 Mhz, which allows the exploration of the interior of the body at different depths in a non-invasive and non-irradiating manner.
Thus, the purpose of the echOpen device is, on one hand, to guide the diagnosis during the clinical examination and, on the other hand, to identify anatomical structures in order to assist in management.
The objective of the clinical investigation is to demonstrate that the echOpen device is able to identify semiological signs and localize anatomical structures at different depths of the body, with a performance not inferior to that of other ultrasound devices, routinely employed in hospital clinical departments.
The signs of interest (i.e. search for an intra-abdominal (3.5 Mhz) and pleural (5.0 Mhz) effusion) were chosen for their clinical usefulness (their presence during the clinical examination constitutes an argument for orientation and/or severity) and for their prevalence in the study population.
The identification of anatomical structure of interest (i.e. detection of basilic vein (7.5Mhz)) was chosen because it is a gesture frequently used when taking in charge of a patient hospitalized in the selected departments.
An ultrasound probe in use in the hospital clinical departments where the investigation takes place will be employed as a comparator to judge the performance of the echOpen device.
This clinical investigation is part of a CE marking procedure.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bobigny, France, 93140
- Avicenne Hospital - APHP - Hepatology Department
-
Paris, France, 75014
- Cochin Hospital - APHP - Emergency Department
-
Paris, France, 75014
- Cochin Hospital - APHP - Pneumology department
-
Villejuif, France, 94800
- Paul Brousse Hospital - APHP - Hepatobiliary Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patient (age ≥ 18 years old)
- Patient having signed the informed consent to participate in this clinical investigation
- Patient affiliated to the social security scheme
- Patient arriving in the hospital clinical ward (own initiative or by emergency services) whose clinical symptomatology (e.g. dyspnea, thoracic pain, etc.) suggests the presence of pathological elements (effusion) which would be visible using an ultrasound probe
- Patient consulting in the hospital clinical ward who could potentially benefit from a basilic vein line placement using an ultrasound device
Exclusion Criteria:
- Minor patient (age < 18 years)
- Patients under the "State medical assistance"
- Obese patient (body mass index > 29.9)
- Patient in too serious condition for the clinical examination to be done fully and/or with additional exploratory time
- Unstable patient: need for immediate care, impossibility to carry out a thorough clinical examination including interview, palpation, auscultation, percussion
- Known allergy to ultrasound gel
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients benefitting ultrasound examination
This is the only arm of the study.
Patients with an indicative clinical picture that leads the clinician to resort to the use of an ultrasound to potentially support the diagnosis will be examined to verify the presence of pleural effusion or intra-abdominal effusion, or to identify basilic vein.
The patients will be assessed first with the echOpen device and second witn an ultrasound routinely used in the department.
In a case of discordance between the assessments made with echOpen and the usual ultrasound device, an independent referent radiologist will use a standard ultrasound machine to constitute the gold standard (GS) rating
|
Depending on the clinical picture, patients are examined to detect the presence or absence of pleural effusion, or intra-abdominal effusion, or to localize the basilic vein
Patients who were first examined with the EchOpen ultra-portable ultrasound device, are secondarily examined with an ultrasound probe used routinely in the department.
In a case of discordance between the assessments made with echOpen and the usual ultrasound device, an independent referent radiologist will use a standard ultrasound machine to constitute the gold standard (GS) rating
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of Pleural effusion
Time Frame: Day 0
|
Presence or absence of pleural effusion as assessed by the echOpen device or by a portable ultrasound routinely used in the department
|
Day 0
|
Presence of Intra-abdominal effusion
Time Frame: Day 0
|
Presence or absence of intra-abdominal effusion as assessed by the echOpen device or by a portable ultrasound routinely used in the department
|
Day 0
|
Basilic vein identification
Time Frame: Day 0
|
Successful identification of the basilic vein using the echOpen device or a portable ultrasound routinely used in the department
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plural effusion detected using a gold standard procedure
Time Frame: Day 0
|
Presence of pleural effusion determined by an independent referent radiologist using a standard ultrasound machine
|
Day 0
|
Intra-abdominal effusion detected using a gold standard procedure
Time Frame: Day 0
|
Presence or absence of intra-abdominal effusion determined by an independent referent radiologist using a standard ultrasound machine
|
Day 0
|
Basilic vein identification using a gold standard procedure
Time Frame: Day 0
|
Identification of the basilic vein by an independent referent radiologist using a standard ultrasound machine
|
Day 0
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jérôme BOKOBZA, MD, AP-HP, Cochin Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP210065
- 2021-A00341-40 (Other Identifier: IDRCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Effusion
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
Oregon Health and Science UniversityThe Gerber FoundationCompletedChylous Pleural Effusion Following Cardiothoracic SurgeryUnited States
-
Sheng HuWuhan Binhui Biotechnology Co., Ltd.RecruitingMalignant Pleural Effusion | Malignant Peritoneal EffusionChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPleural NeoplasmUnited States
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia
-
JemincareZhejiang Hangyu Pharmaceutical Co., LtdRecruitingMalignant Pleural EffusionChina
-
National University of Ireland, Galway, IrelandRecruitingMalignant Pleural EffusionIreland
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruiting
-
Washington University School of MedicineMerit Medical Systems, Inc.CompletedMalignant Pleural EffusionUnited States
-
Duke UniversityTerminated
Clinical Trials on EchOpen ultra-portable ultrasound device
-
Assistance Publique - Hôpitaux de ParisEIT Health; ECHOPENCompletedEfficacy of the echOpen Device to Detect Pyelocaliceal Dilation and Hepatic Steatosis (CLIN-ECHO-II)Fatty Liver | Hepatic Steatosis | HydronephrosisFrance
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingIV Line Placement With UltrasoundFrance
-
echOpen FactoryInstitut Pasteur de Dakar; Fondation Sanofi EspoirNot yet recruiting
-
Yale UniversityButterfly Network, IncCompletedVoiding Disorders | Voiding DysfunctionUnited States
-
European e-Learning School in Obstetric AnesthesiaUniversity of Milano BicoccaCompletedObesity | Pregnancy RelatedItaly
-
Temple UniversityCompleted
-
Centre Hospitalier Universitaire de NīmesTerminated
-
TakedaTakeda Development Center Americas, Inc.CompletedHealthy Volunteers | Narcolepsy Type 1United States
-
Bridge to Health Medical and DentalKigezi Healthcare FoundationCompletedMaternal Health | Antenatal Care
-
Massachusetts General HospitalNot yet recruitingUltrasound Therapy; Complications